H. Kerkhofs

863 citations
18 papers · 691 indexed · h-index 9
Topics
Acute Myeloid Leukemia Research (8 papers)Lymphoma Diagnosis and Treatment (6 papers)Chronic Lymphocytic Leukemia Research (4 papers)
Partner nations
NetherlandsItalyGermany

In The Last Decade

H. Kerkhofs

16 papers receiving 666 citations

Peers

H. Kerkhofs
Comparison fields: 5 of 47
  • Hematology 619
  • Molecular Biology 218
  • Public Health, Environmental and Occupational Health 205
  • Genetics 177
  • Oncology 144
Replace G V Dahl with:
G V Dahl United States
A. Kuendgen Germany
Michael J. Keating United States
A. Cantù Rajnoldi Italy
U. Creutzig Germany
Kathrin Nachtkamp Germany
E. Pittermann Austria
CA Hurwitz United States
Hege Garelius Sweden
Ilaria Ambaglio Italy
H. Kerkhofs relative to G V Dahl United States G V Dahl's profile →
Citations per field
00.5×
G V Dahl · 1×
Citations per year

Countries citing papers authored by H. Kerkhofs

Since Specialization
Citations

This map shows the geographic impact of H. Kerkhofs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kerkhofs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kerkhofs more than expected).

Fields of papers citing papers by H. Kerkhofs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kerkhofs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kerkhofs. The network helps show where H. Kerkhofs may publish in the future.

Co-authorship network of co-authors of H. Kerkhofs

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kerkhofs. A scholar is included among the top collaborators of H. Kerkhofs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kerkhofs. H. Kerkhofs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
5
3 32
4 2
5 302
6 160
7 23
8
Population-based registration of non-Hodgkin lymphoma in the region covered by the Comprehensive Cancer Centre West. The registry of diagnosis and therapy.
9
9 8
10 74
11
Results of a multicentre study of the treatment of acute lymphoblastic leukaemia in adolescents and adults (1978-1981).
1
12 4
13 27
14 37
15
[Hematuria as a symptom of the "hospital addiction" syndrome].
2
16 2
17 1
18 2

About H. Kerkhofs

H. Kerkhofs is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 18 papers that have together received 691 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (619 citations), Genetics (177 citations) and Emergency Medicine (72 citations). H. Kerkhofs has collaborated with scholars based in Netherlands, Italy and Germany. Frequent co-authors include C. H. W. Leeksma, H. L. Haak, J. Hermans, J. Abels, G. Solbu, C Cauchie, R Zittoun, M. Peetermans, Bob Löwenberg and U. Jehn. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026